Skip to main content

UBS Group AG

Position in SLGL — Sol-Gel Technologies Ltd.

CIK 1610520 ZURICH, V8

Position in SLGL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$30,841
-$24,137 QoQ
Shares Held
416
-40.1% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 24 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. SLGL ranks #410 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SLGL

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $30,841 416
2026-03-31 $54,978 694
2025-12-31 $53,643 1,273
2025-06-30 $54,293 7,337
2025-03-31 $19,806 38,089
2024-12-31 $19,769 21,258
2024-09-30 $2,351 3,459
2024-03-31 $3,336 3,405
2023-12-31 $11,729 10,615
2023-06-30 $1,369 458
2022-12-31 $13,602 2,983
2022-03-31 $4,841 656
2021-12-31 $11,329 1,531
2021-09-30 $5,450 545
2021-06-30 $99,634 8,048
2021-03-31 $2,389 193
2020-12-31 $186 19
2020-09-30 $58,586 8,092
2020-06-30 $15,005 1,676
2020-03-31 $2,054 291